PMID: 2510041Sep 1, 1989Paper

Additional arrows for the beta-amyloid target

Neurobiology of Aging
B Cordell

Abstract

Currently, numerous postulates exist to explain the mechanism of beta-amyloid genesis. Fortunately, many molecular tools also exist to conduct the experiments which will identify the correct mechanism. In the process, therapeutic targets for Alzheimer's disease will be revealed.

References

Mar 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D SchubertG Cole
Feb 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·S B ZainC A Marotta
Oct 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D J SelkoeT Oltersdorf
Oct 14, 1988·Biochemical and Biophysical Research Communications·M R PalmertS G Younkin

❮ Previous
Next ❯

Citations

Jun 1, 2006·The Journal of Pharmacy and Pharmacology·Kornkanok IngkaninanKhanit Suwanborirux
May 5, 2012·Angewandte Chemie·Jennifer M FinefieldRobert M Williams

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Related Papers

Medical Hypotheses
B I Gerashchenko
Microbes and Infection
Joshua D Nosanchuk, Attila Gacser
Southern Medical Journal
H Noack, J F Rothrock
Nature Reviews. Drug Discovery
Tim TullyJohn Tallman
© 2022 Meta ULC. All rights reserved